Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 24.14 is 23% above its 5-year average of 19.57, near the low end of its 5-year range (6.74–71.49).
As of the fiscal period ended Tuesday, June 30, 2026. 3.94% below its 12-month average of 25.13.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 24.14.
QUICK RATIO (ACID-TEST)
24.14
QUICK RATIO (ACID-TEST) AVG TTM
25.13
QUICK RATIO (ACID-TEST) AVG 3Y
22.58
QUICK RATIO (ACID-TEST) AVG 5Y
19.57
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-3.94%
CURRENT VS 3Y AVG
+6.89%
CURRENT VS 5Y AVG
+23.36%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.15
median of 685 covered companies
CURRENT VS SECTOR MEDIAN
+666.21%
vs the sector median at left
Disc Medicine, Inc.
Market Cap
$2.47B
Quick Ratio (Acid-Test)
24.14
TTM Avg
25.13
3Y Avg
22.58
5Y Avg
19.57
Market Cap
$2.42B
Quick Ratio (Acid-Test)
10.23
TTM Avg
3.96
3Y Avg
3.96
5Y Avg
3.96
Market Cap
$2.43B
Quick Ratio (Acid-Test)
5.03
TTM Avg
4.66
3Y Avg
4.92
5Y Avg
7.11
Market Cap
$2.41B
Quick Ratio (Acid-Test)
1.50
TTM Avg
1.54
3Y Avg
1.54
5Y Avg
1.56
Market Cap
$2.38B
Quick Ratio (Acid-Test)
3.81
TTM Avg
3.32
3Y Avg
2.77
5Y Avg
2.91
Market Cap
$2.38B
Quick Ratio (Acid-Test)
6.34
TTM Avg
6.74
3Y Avg
5.35
5Y Avg
5.47
Market Cap
$2.36B
Quick Ratio (Acid-Test)
2.12
TTM Avg
2.91
3Y Avg
5.50
5Y Avg
6.00
Market Cap
$2.59B
Quick Ratio (Acid-Test)
1.62
TTM Avg
1.73
3Y Avg
1.84
5Y Avg
1.83
Market Cap
$2.64B
Quick Ratio (Acid-Test)
9.03
TTM Avg
7.98
3Y Avg
9.04
5Y Avg
8.34
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Disc Medicine, Inc. (IRON) | $2.47B | 24.14 | 25.13 | 22.58 | 19.57 |
| Alamar Biosciences, Inc. (ALMR)vs › | $2.42B | 10.23 | 3.96 | 3.96 | 3.96 |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.43B | 5.03 | 4.66 | 4.92 | 7.11 |
| Clover Health Investments, Corp. (CLOV)vs › | $2.41B | 1.50 | 1.54 | 1.54 | 1.56 |
| ADMA Biologics, Inc. (ADMA)vs › | $2.38B | 3.81 | 3.32 | 2.77 | 2.91 |
| Nurix Therapeutics, Inc. (NRIX)vs › | $2.38B | 6.34 | 6.74 | 5.35 | 5.47 |
| Liquidia Corporation (LQDA)vs › | $2.36B | 2.12 | 2.91 | 5.50 | 6.00 |
| Privia Health Group, Inc. (PRVA)vs › | $2.59B | 1.62 | 1.73 | 1.84 | 1.83 |
| NewAmsterdam Pharma Company N.V. (NAMS)vs › | $2.64B | 9.03 | 7.98 | 9.04 | 8.34 |
| Harmony Biosciences Holdings, Inc. (HRMY)vs › | $2.32B | 3.45 | 3.42 | 3.65 | 3.62 |
Quick Ratio
24.14
Excludes inventory
Current Ratio
24.14
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 24.14 |
| 2026-03-31 | 24.00 |
| 2025-12-31 | 21.94 |
| 2025-09-30 | 23.45 |
| 2025-06-30 | 32.11 |
| 2025-03-31 | 37.65 |
| 2024-12-31 | 21.17 |
| 2024-09-30 | 19.36 |
| 2024-06-30 | 25.02 |
| 2024-03-31 | 23.70 |
| 2023-12-31 | 17.06 |
| 2023-09-30 | 25.96 |
| 2023-06-30 | 39.42 |
| 2023-03-31 | 24.26 |
| 2022-12-31 | 8.79 |
| 2022-09-30 | 71.49 |
| 2022-06-30 | 17.58 |
| 2022-03-31 | 9.79 |
| 2021-12-31 | 6.74 |
| 2021-09-30 | 12.23 |
| 2021-06-30 | 14.89 |
| 2021-03-31 | 13.69 |
| 2020-12-31 | 0.20 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
